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Abstract 
BACKGROUND AND AIM: The biopsy of an oral mucosal lesion is a minor operation. Pain might be an unpredictable 
consequence of the oral mucosal biopsy. The aim of this study was to examine the incidence and severity of post-
operative pain following the biopsy of oral mucosal lesions in patients attending in an oral medicine department of 
Kerman Dental School. 
METHODS: Visual analogue scale (VAS) was used to assess post-operative pain in 60 patients. Seven days after the 
biopsy of oral mucosa, patients were asked about overall pain experiences and analgesic usage over 3 days following 
the biopsy. 
RESULTS: Forty percent of patients reported moderate pain in the day of the biopsy and 58% of patients experienced no 
pain in the third day after the biopsy. Thirty percent of patients used analgesic in the day of the biopsy and there was not 
any relationship between the average level of patient's pain and the location of the lesion removal, type of biopsy, type 
of coverage, maximum diameter and type of the lesions (P > 0.05). 
CONCLUSIONS: Pain after biopsy from oral mucosal lesion is mild to moderate. 
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iopsy is the oldest and the most exact 
method used for definite diagnosis of 
different lesions in dentistry.1 Correct 
treatment of the patient with an oral 
lesion begins with an exact diagnosis and the 
gold standard is histopathologic evaluation 
of tissue specimen of the lesion.2-5 In some 
oral mucosal lesions, delay in removal can 
cause disease progression and poor 
prognosis.6 Biopsy is prescribed for majority 
of oral mucosal lesions (including 
mucocutaneous lesions, precancerous and 
suspicious lesions to malignancy).7 Two 
common types of taking biopsy include 
incisional and excisional biopsy.8 Other 
techniques such as fine needle aspiration, 
exfoliative cytology, cytobrush techniques 
and toluidine blue staining are 
complementary methods and performing 
each method alone is not enough for a 
definitive diagnosis.9-16 
Correct specimen should include a tissue 
that shows the most evident and intensive 
changes and it is also sufficient for pathologic 
evaluation. Access to such specimen will be 
gained by careful attention to some points 
such as the specimen dimension, the correct 
site of specimen removal, management of the 
unpredictable consequences such as excessive 
bleeding, fixation of specimen, specimen 
carriage and enough attention to healing of 
the biopsied region.3,4,7,17 Biopsy sometimes is 
accompanied with complications such as lip 
and tongue paresthesia, swelling and 
hematoma in tissues and trauma to salivary 
gland duct. Dentist’s and patient’s concern 
for such complications has caused the biopsy 
to be less common in dentistry.18- 21 
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Camacho-Alonso and Lopez-Jornet 
evaluated the level of pain after a biopsy 
from an oral mucosa using visual analogue 
scales (VAS) in 84 patients. They recorded 
maximum pain after biopsy of the oral 
mucosa during the first 48 hours, after which 
it gradually reduced.22 
Kearns et al. evaluated the level of pain 
after a biopsy from an oral mucosa in 85 
patients during 7 days after procedure. In the 
results of this research, 39% of patients did 
not complain about any pain on the first day, 
although it increased toward the seventh day 
(79%).23 Lodi et al. evaluated their experience 
on the day of the biopsy and 7 days after that 
in 286 patients. 78% of patients had used 
analgesics in post-operative days.24 
An awareness of pain score related to 
operative procedures helps clinicians prepare 
their patients for decreasing these 
complications. On the other hand, some of 
the experts in this field do not believe in the 
prescription of analgesics for these patients.2 
Although many investigators have studied 
pain experience after different dental 
treatments complications such as teeth 
extraction or root canal therapy, 
investigations concerning the pain after 
biopsy from mucosa have not been 
remarkable. The present study was carried 
out to evaluate the score and intensity of pain 
following biopsy form oral mucosa. 
Methods 
This quasi-experimental study took place in 
Department of Oral Medicine in Kerman 
Dental School. Consecutive patients 
undergoing biopsy of oral mucosal lesions 
were recruited into the study. These patients 
were above 12 years old. The subjects were 
excluded from the study in case of any 
systemic disease such as gastro-intestinal 
diseases, having any psychic or neurological 
pain or taking medicine such as analgesics or 
anti-inflammatory drugs in the last three 
days. Patients with painful oral lesion before 
biopsy were excluded too. Research 
objectives were explained for patients and a 
written consent was obtained from the 
volunteers prior to the commencement of the 
study. 
Biopsy was done under sterilized and 
standard conditions by scalpel (No.15, model 
Wuxi X.D Medical Device Co., China). The 
tissue specimen had the maximum extent of 3 
centimeters and the depth of all specimens 
was ultimately to the submucosal area and 
did not include periosteum and muscles. 
Biopsy was done by an experienced oral 
medicine specialist. The coverage of sites of 
biopsy was in primary form using silk 
suturing thread 3 zero (maximum 2 suture) 
or Coe-pack dressing according to clinical 
diagnosis.22,23 The patients could use 
analgesic for post-operative pain if needed 
(ibuprofen 400 mg tablet QID).  
Each patient was given a form to complete 
for each of the 3 post-operative days. Patients 
were instructed to note 3 items for each day: 
the overall level of pain, the worst pain 
experienced and whether analgesics had been 
taken. The overall and worst pain levels were 
recorded using visual analogue scales (VAS), 
each consisting of a 100 mm calibrated line on 
white paper, marked 0 to 10 at 10 mm 
intervals. Patients were informed that a score 
of 0 indicated ‘no pain at all’ while a score of 
10 indicated ‘the pain could not be worse’. 
Patients were instructed to record the pain 
experience of the previous day each morning 
by marking a point on the VAS for overall 
pain and by answering ‘yes’ or ‘no’ to the 
question on the analgesic use. Pain scores 
were also categorized as ‘none’, ‘mild’, 
‘moderate’, or ‘severe’.  
An information collection form was filled 
for all patients including the date of biopsy, 
clinical diagnosis, patient’s age and sex, exact 
location of the lesion removal, type of biopsy 
and type of coverage and whether specimen 
has been removed from keratinized or non-
keratinized mucosa. Collected data was 
analyzed by SPSS software (version 17; SPSS 
Inc., Chicago, IL., USA). Chi-square test was 
used to compare nominal data and Student’s  
t-test to compare quantitative data. Significance  
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level in all tests was assumed to be 0.05. 
Results 
Sixty patients took part in the present study. Of 
them, 25 (41.7%) were male and 35 (58.3%) 
were female. We divided our patients into 
three age groups (< 40, 40-60 and > 60 years 
old; Table 1). The mean (± SD) age of subjects 
was 45.8 ± 12.8 years. 
The most frequent biopsy region was in 
buccal mucosa (47%) and after it, the lip, 
gingival and palate were placed next, 
respectively (25%, 16% and 10%).The least 
biopsy had been done on patients’ tongue 
(3%). Thirty percent of biopsies were done in 
keratinized mucosa and 70% in non-
keratinized mucosa. 43.3% of biopsies were 
done by incisional and 56.6 by excisional 
techniques. 
Healing of specimen removal region was 
done in primary form in 93.3% of cases. The 
most frequent size of lesion was those greater 
than 2 centimeters (56.6%) and also the least  
was the lesions smaller than 1 centimeter 
(15.0%). From the clinical diagnosis 
viewpoint, the most frequent lesions were 
exophytic lesions (51.6%) and the least ones 
were pigmented lesions (1.6%) (Table 1). 
The intensity of pain was evaluated using 
a VAS and was compared in terms of age 
groups, sex, site of lesion, type of mucosa, 
type of biopsy, type of coverage, the largest 
diameter and type of lesion. When the 
median pain scores were analyzed among 
these variables, there was no significant 
difference (P > 0.05; Table 1). The average 
pain scores were not affected by these 
demographic and clinical parameters. 
Figure 1 shows severity of pain 
experienced by patients at the day of biopsy 
and the first to the third days after biopsy 
based on their description. As shown, the 
highest frequency of pain severity was 
related to moderate pain with the highest 
percentage at the day of biopsy (40%). On the 
first day after the biopsy, 22 patients (36.6%)  
 
Table 1. Comparison of pain scores among the different characteristics groups of participants 
Variation Median (range) Pain Frequency (%) P-value 
Age groups* 
< 40 years 1.25 (0-5) 19 (32.7) 
0.9461 40-60 years 1.25 (0-9) 28 (48.2) 
> 60 years 1.5 (0.75-4.75) 11 (18.9) 
Gender** Male 1.25 (0-4.75) 25 (41.6) 0.1502 Female 1.75 (0-9) 35 (58.3) 
Location 
Lip 1.25 (0-5.5) 15 (25.5) 
0.2889 
Tongue 2 (0-4) 2 (3.33) 
Buccal mucosa 2.25 (0-9) 25 (41.4) 
Palate 1 (0-7.5–1.75) 6 (10.0) 
Gingiva 1.375 (0-4.75) 10 (16.6) 
Others 0.5 (0-1) 2 (3.33) 
Mucosa Keratinized 1 (0-4.75) 18 (30.0) 0.2532 Non-Keratinized 1.625 (0-9) 42 (70.0) 
Type of Biopsy Incisional 1.75 (0-6.5) 26 (43.3) 0.5488 Excisional 1.25 (0-9) 34 (56.6) 
Type of Coverage 
Suture 1.25 (0-6.5) 47 (78.3) 
0.4130 Co-Pack 1 (0.25–9) 9 (15.0) 
Without 2 (1.75-4.75) 4 (6.67) 
Maximum size*** 
< 1 cm 1.75 (0-6.5) 8 (15.0) 
0.0871 1-2 cm 1.25 (0-3.25) 15 (28.3) 
> 2 cm 1.875 (0-9) 30 (56.6) 
Type of lesion 
Ulcer 2 (0-5.5) 16 (26.6) 
0.2078 
White lesion 1.125 (0-6.5) 10 (16.6) 
Exophytic lesion 1.5 (0-9) 31 (51.6) 
Pigmented Lesion 1 (1-1) 1 (1.67) 
Others 0.375 (0-0.75) 2 (3.33) 
* n = 58, ** n = 60, *** n = 53 
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Figure 1. Frequency of different level of pain in the day of biopsy and three days after it 
 
recorded mild pain. On the second day, 31 
patients (57.6%) recorded overall pain levels 
corresponding to “none”. This rose to 35 
patients (58.3%) on the third day after the 
procedure. It seems that from patients’ point 
of view, the pain after biopsy from oral 
mucosa was mild to moderate that often 
existed on the day of biopsy and on the first 
day after this procedure. 
Maximum dose of analgesics used was 
related to the day of specimen removal (30%); 
it gradually decreased from the first to the 
third day after biopsy (18% on the day after 
biopsy and 10% on the second day). On the 
third day after biopsy, only 8.3% of patients 
used analgesics. 
Discussion 
In the present study, the recording of pain 
with VAS during three days after oral 
mucosal biopsy did not exceed 2.25 in any 
cases. Because of the subjective nature of pain 
and since it is accompanied by other 
sensations, there is not definitive evaluation 
system for it and also numerous factors such 
as variety of patients’ personalities and 
cultural and social factors affect patients’ 
response to pain. This makes it difficult to 
evaluate the pain after medical or dental 
procedure. However, the dose of analgesics 
needed to reduce more than half of the pain, 
expressing the severity of pain by patient 
qualitatively and VAS are commonly used in 
studies that investigate such pains; the 
present study applied the all three 
methods.2,22,23 Kearns et al. believed that it is 
not suitable to measure pain after it occurs 
because of the fact that patients should 
remember it.23 
In the present study, there was no 
significant relationship between average pain 
score after biopsy and site of the lesion. In 
Camacho-Alonso and Lopez-Jornet study, 
although the highest level of pain score was 
reported from floor of the mouth biopsy 
specimens, no significant differences were 
found.22 It should be mentioned that in our 
study, none of mucosal specimens was from 
the floor of the mouth. In Kearns et al. study, 
maximum dose of analgesics consumption was 
in specimens form gingiva. However, none of 
the three patients whose site of specimen 
removal was floor of the mouth used drug for 
pain relief in Kearns et al. study.23 
Comparison of these two different criteria 
for evaluating the degree of pain (analgesics 
use versus VAS) showed a contradiction 
between this study and Camacho-Alonso and 
Lopez-Jornet study.22 In the present study, 
there was no significant relationship between 
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the level of patients’ pain and type of biopsy 
(incisional versus excisional) that is similar to 
Camacho-Alonso and Lopez-Jornet study. 
Moreover, the present study which 
investigated the relation of variables such as 
kind of coverage, site of biopsy, maximum 
diameter of the lesions, type of the lesions 
and type of mucosal region of specimen 
removal, indicated no significant relationship 
with severity level of patients’ pain. In 
similar studies, however, the mentioned 
variables were not studied.2,22,23 
In Camacho-Alonso and Lopez-Jornet 
study, average pain level in females was 
significantly higher than that of men, but no 
significant relationship was found between 
patients’ age and pain level. In the present 
study, conditions similar to Camacho-Alonso 
study were found concerning age, but they 
were different regarding sex.22 
Maximum frequency of pain level 
described by patients in the present study has 
been related to the day of specimen removal; it 
was similar to Camacho-Alonso and Lopez-
Jornet22 and Kearns et al.23 studies and it seems 
that this pain like other kinds of post-
operative pain (such as extraction) had a 
tendency to begin after elimination of local 
anesthesia and reached maximum level 
during the day of biopsy. 
The results of the present study were 
similar to Camacho-Alonso and Lopez-Jornet 
study22 regarding average pain level with 
utilization of VAS and were similar to Kearns 
et al. study23 regarding maximum frequency 
of pain intensity (moderate pain). 
In results of the present study, dose of 
analgesics was reduced in patients at the day 
after biopsy and a significant relationship 
was observed between intensity of pain and 
analgesics use. However, the relationship 
between pain and analgesics use had not 
been evaluated in similar studies. 
In Kearns et al. study, 70% of patients 
used analgesics at least once on biopsy day or 
afterwards.23 In Camacho-Alonso and Lopez-
Jornet study, an average of 60% of patients 
used these drugs for two days.22 In Lodi et al. 
study, 18% of patients did so.24 However, in 
the present study, 30% of patients took 
analgesic on the day of biopsy and on the 
first day after biopsy it was 78%. 
One of the limitations of this study and 
other similar studies was the multi-factorial 
nature of pain. It means that several factors 
including cultural background, personality and 
level of anxiety, memory and previous 
experiences can all have an influence on pain.  
It is observed that dose of analgesic in 
patients with oral mucosal lesion biopsy in 
different studies had different levels and this 
issue could be the result of the difference in 
drug using habits in different societies and 
the fact that many patients start using 
prophylactic analgesics drug without 
dentists’ prescription and continue it even in 
the lack of pain experience. It should be 
mentioned that misuse of non-steroidal anti-
inflammatory drugs which are often used for 
relieving such pains can lead to various side 
effects such a digestive disorders (gastritis 
and peptic ulcer) and bleeding disorder. 
Conclusion 
The results of the present study showed that 
pain after biopsy from oral mucosal lesion is 
mild to moderate. In a few percentages of 
patients, there is a need of analgesic 
prescription after the procedure but clinical-
trial study is recommended for more 
definitive prescription of analgesics by the 
dentist. Regarding the existing data, 
clinicians who are doing this can advise their 
patients to use analgesics in the case of pain 
after biopsy.  
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